GConferenceGridThe Conference Catalogue · Vol. 2026Folio № ED9245
Healthcare & Medical

ASCO 2026: Designing the Next Generation of Oncology Trials

A

t ASCO 2026, Syneos Health highlights how adaptive oncology trial design can translate emerging science into faster, more meaningful outcomes for patients. The conference focuses on evolving oncology trial designs to support earlier insights, confident development decisions, and accelerated patient access. Key themes include MRD-driven strategies, advanced…

Visit the official site
0Voices
1Underwriters
1Exhibitors
0On the bill · sessions
1Companies · in total
§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Syneos Health
Intermission
Part the Second · For the Buyer

What does it mean when 1 companies show up — and 1 bet on three roles at once?

“One companies. one are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
1All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
0Speakingspeaker only

The Triple-Threat

Syneos Health

№ 03Fig. 03 — The Heaviest in the Room
  1. 01Syneos HealthSpEx
№ 04Fig. 04 — By Tier
unspecified1
100% of 1

Sister convocations

Same brand, other regions